BR0314668A - Utilização de excipientes para aumentar a captação de dna por células musculares de suìno - Google Patents

Utilização de excipientes para aumentar a captação de dna por células musculares de suìno

Info

Publication number
BR0314668A
BR0314668A BR0314668-5A BR0314668A BR0314668A BR 0314668 A BR0314668 A BR 0314668A BR 0314668 A BR0314668 A BR 0314668A BR 0314668 A BR0314668 A BR 0314668A
Authority
BR
Brazil
Prior art keywords
excipients
suine
muscle cells
dna
nucleic acids
Prior art date
Application number
BR0314668-5A
Other languages
English (en)
Inventor
Paula Joan Gaynor
Lynn David Nelson
Rajendra Krishnan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0314668A publication Critical patent/BR0314668A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"UTILIZAçãO DE EXCIPIENTES PARA AUMENTAR A CAPTAçãO DE DNA POR CéLULAS MUSCULARES DE SUìNO". A presente invenção refere-se a novas formulações de excipientes para distribuição de ácidos nucléicos, particularmente DNA não-ligado, através de membranas celulares in vivo. A presente invenção também proporciona um aumento da penetração que pode ser utilizado para aumentar a distribuição e captação por células de uma larga variedade de ácidos nucléicos particularmente agentes terapêuticos ou molécula de DNA contendo um gene codificando uma proteína que pode beneficiar animais normais, especialmente na aplicação da terapêutica genética e melhorando a viabilidade ou taxa de sobrevivência de animais de criação recém-nascidos.
BR0314668-5A 2002-09-26 2003-09-16 Utilização de excipientes para aumentar a captação de dna por células musculares de suìno BR0314668A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41372202P 2002-09-26 2002-09-26
PCT/IB2003/004109 WO2004028442A2 (en) 2002-09-26 2003-09-16 Use of excipients to increase dna uptake by swine muscle cells

Publications (1)

Publication Number Publication Date
BR0314668A true BR0314668A (pt) 2005-08-02

Family

ID=32043280

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314668-5A BR0314668A (pt) 2002-09-26 2003-09-16 Utilização de excipientes para aumentar a captação de dna por células musculares de suìno

Country Status (9)

Country Link
US (1) US20050009770A1 (pt)
EP (1) EP1545432A4 (pt)
JP (1) JP2006500420A (pt)
AU (1) AU2003263466A1 (pt)
BR (1) BR0314668A (pt)
CA (1) CA2499533A1 (pt)
MX (1) MXPA05002419A (pt)
PL (1) PL375961A1 (pt)
WO (1) WO2004028442A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110426264B (zh) * 2019-08-27 2022-03-22 阜阳师范大学 一种脂肪细胞的染色方法及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739118A (en) * 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
AUPM747694A0 (en) * 1994-08-16 1994-09-08 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids and peptides
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
WO1998010649A1 (en) * 1996-09-13 1998-03-19 University Technology Corporation Biocompatible cationic detergents and uses therefor
US6261281B1 (en) * 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
CA2297375A1 (en) * 1997-07-24 1999-02-04 Valentis, Inc. Ghrh expression system and methods of use
US6376471B1 (en) * 1997-10-10 2002-04-23 Johns Hopkins University Gene delivery compositions and methods
US20020055702A1 (en) * 1998-02-10 2002-05-09 Anthony Atala Ultrasound-mediated drug delivery
AU780270B2 (en) * 2000-02-23 2005-03-10 Association Francaise Contre Les Myopathies Treatment of immune diseases
EP1309904A4 (en) * 2000-03-03 2006-03-29 Valentis Inc IMPROVED POLOXAMER AND POLYOAMINE COMPOUNDS FOR NUCLEINE SUCTION INTRODUCTION
EP1278551A2 (en) * 2000-04-21 2003-01-29 Vical Incorporated Compositions and methods for (in vivo) delivery of polynucleotide-based therapeutics
WO2003066825A2 (en) * 2002-02-07 2003-08-14 Baylor College Of Medicine Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy

Also Published As

Publication number Publication date
EP1545432A4 (en) 2007-03-14
US20050009770A1 (en) 2005-01-13
WO2004028442A3 (en) 2004-07-15
WO2004028442A2 (en) 2004-04-08
CA2499533A1 (en) 2004-04-08
MXPA05002419A (es) 2005-05-27
PL375961A1 (en) 2005-12-12
AU2003263466A1 (en) 2004-04-19
EP1545432A2 (en) 2005-06-29
JP2006500420A (ja) 2006-01-05

Similar Documents

Publication Publication Date Title
BR0012069A (pt) Composições e métodos para a terapia e diagnóstico de câncer pulmonar
ES2167365T3 (es) Vectores adenovirales de origen animal y utilizacion en terapia genica.
DE69922933D1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
YU102203A (sh) Vakcinacija sa jednokratnom dozom mycoplasma hyopneumoniae
CY1114679T1 (el) Συνθεσεις για διαγνωση και θεραπεια ασθενειων που συνδυαζονται με παρεκκλινουσα εκφραση φουτρινων (r-σπονδινων)
BR0211049A (pt) Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae
DE60237768D1 (de) Modulatoren pharmakologischer mittel
WO2003104270A3 (en) GENES OF DUDULINE 2, EXPRESSION PRODUCTS, NON-HUMAN ANIMAL MODEL: USES IN HUMAN HEMATOLOGICAL DISEASES
ES2572835T3 (es) Fragmento de agrina modificado capaz de restituir la fuerza muscular, para su uso como medicamento
ATE462449T1 (de) Benutzung von alpha (1,3) -galactosyltransferase exprimierenden allogenen tumorzellen zur impfung gegen tumoren
DE602004030353D1 (de) Formulierungen enthaltend salicylate und deren verwendung zur behandlung von entzündlicher darmerkrankung
TNSN03154A1 (fr) Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux.
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
DE59510466D1 (de) Lebendvakzine zur behandlung von tumorerkrankungen
Fujiyoshi et al. The difference in temporal distribution of c-Fos immunoreactive neurons between the medullary dorsal horn and the trigeminal subnucleus oralis in the rat following experimental tooth movement
Moon et al. From animal models to humans: strategies for promoting CNS axon regeneration and recovery of limb function after spinal cord injury
BR0208962A (pt) Método para liberar in vivo um oligonucleotìdeo quimérico para dentro de células alvo de um tecido humano ou animal, para tratar uma doença, para obter um modelo animal, para selecionar compostos cosméticos ou farmacêuticos, para tratar um hospedeiro humano possuindo retinopatia e para tratar um hospedeiro humano ou animal possuindo neovascularização ocular, aligonucleotìdeo quimérico, composição farmacêutica, modelo animal, e, uso do mesmo
Howell et al. Investigating sodium valproate as a treatment for McArdle disease in sheep
BR0314668A (pt) Utilização de excipientes para aumentar a captação de dna por células musculares de suìno
TW200724679A (en) Treatment of disease using an improved regulated expression system
WO2004087752A3 (en) Spinster-like protein genes, expression products, non-human animal model: uses in human metabolic disorders
CN101951942A (zh) Mntf肽组合物及使用方法
EA200700346A1 (ru) Бактериофаг- и профаг-специфические протеины в генной терапии рака
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
ATE239749T1 (de) Phosphor-enthaltende dendrimere als transfektionsagente

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE 4A., 5A., 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.